Comment on: Doravirine plus lamivudine two-drug regimen as maintenance antiretroviral therapy in people living with HIV: a French observational study

J Antimicrob Chemother. 2023 Dec 1;78(12):3009-3010. doi: 10.1093/jac/dkad318.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anti-Retroviral Agents / therapeutic use
  • HIV Infections* / drug therapy
  • Humans
  • Lamivudine* / therapeutic use
  • Pyridones / therapeutic use
  • Triazoles

Substances

  • Lamivudine
  • Anti-Retroviral Agents
  • Pyridones
  • doravirine
  • Triazoles